• Corpus ID: 116040516

Journal of Neurology & Translational Neuroscience

  title={Journal of Neurology \& Translational Neuroscience},
  author={Moses Rodriguez}

Figures from this paper


Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.
This study supports the hypothesis that expression of viral capsid proteins as self and subsequent genetic deletion of capsid-specific T cells influences the extent of spinal cord remyelination following Theiler's virus-induced demyelinations and proposes that VP1- and, to a lesser extent, VP2-specific CD8+ T cells limit and/or prevent the naturally occurring process of remYelination.
CD8+ T cells in multiple sclerosis
The theoretical roles of different CD8+ T-cell subsets in MS are discussed, finding increasing evidence exists for the role of regulatory, IL-17-secreting CD8+, which may damage the nervous system.
Immunosuppression promotes CNS Central
  • Immunosuppression promotes CNS Central
  • 2013
Deletion of Beta‐2‐Microglobulin Ameliorates Spinal Cord Lesion Load and Promotes Recovery of Brainstem NAA Levels in a Murine Model of Multiple Sclerosis
This study further supports the hypothesis that CD8+ T cells are involved in demyelination, and axonal loss following Theiler's virus‐induced demYelination.
The relevance of animal models in multiple sclerosis research.
Transgenic Expression of Viral Capsid Proteins Predisposes to Axonal Injury in a Murine Model of Multiple Sclerosis
The hypothesis that expression of viral capsid proteins as self influences the extent of axonal pathology following Theiler's virus–induced demyelination is supported and insight is provided into the role ofAxonal injury in the development of functional deficits that may have relevance to human demyELinating disease.
Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: Marker of demyelination and repair in spinal cord
Using magnetic resonance spectroscopy (MRS) as a surrogate for spinal cord injury in two mouse strains with different reparative phenotypes following virus‐induced demyelination, brainstem MRS may be a viable endpoint to represent overall spinal cord dysfunction.
Progressive multifocal leukoencephalopathy after natalizumab monotherapy.
We describe progressive multifocal leukoencephalopathy (PML) caused by infection with human polyomavirus JC virus in a patient with multiple sclerosis who was treated with natalizumab. The first PML
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
In patients with early, relapsing-remitting multiple sclerosis, alemtuzumab was more effective than interferon beta-1a but was associated with autoimmunity, most seriously manifesting as immune thrombocytopenic purpura.